| Scorecard |
|---|
|
2 / 5 Stars
|
|
Lipper
4
5
1
5
3
|
|
Zacks Investment Research
1
(Strong Buy)
|
|
Standard & Poor's
3 / 5 Stars
|
|
TheStreet.com
C+
(Hold)
|
Fund Fees
Updated 09.30.2012
| Maximum Sales Fees % | |
|---|---|
| Initial | |
| Deferred |
Updated 09.30.2012
| Maximum Fees % | |
|---|---|
| Administrative | 0.25 |
| Management | 0.9 |
| Redemption |
Updated 09.30.2012
| Actual Fees % | |
|---|---|
| 12b-1 | 0.25 |
| Management | 0.9 |
| Net Expense Ratio: Annual Report | 1.66 |
| Net Expense Ratio: Prospectus | 1.67 |
Updated 05.03.2013
| Total Cost Projections | |
|---|---|
| 3-Year | $526.00 |
| 5-Year | $907.00 |
| 10-Year | $1,976.00 |
Purchase Information
Updated 08.01.2012
| Minimum Investments | |
|---|---|
| Initial | $2,500.00 |
| Additional | $0.00 |
| Initial IRA | $1,000.00 |
| Additional IRA | $0.00 |
| Initial AIP | |
| Additional AIP |
